Compared to germinal center B-cell-like lymphoma, the activated B-cell like subtype of DLBCL present poor response to current therapy and often exhibit overexpression or hyperactivation of STAT3 [36]. The gene discussed is STAT3; the disease is diffuse large B-cell lymphoma.